The future CRO/CDMO will offer end-to-end solutions and operate as a large pharma or biotech company Lakshmipriya Nair Oct 6, 2021 Dr Mahesh Bhalgat, COO, Syngene talks about his company's outlook, investments and capacity expansion, as well as Syngene's plans…
